KRAS Mutations in Unresectable Colorectal Liver Metastases Linked to Reduced Response Rates
March 18th 2021Based on a single-institution study, investigators were able to correlate outcomes for unresectable colorectal liver metastases with the addition of hepatic arterial infusion pump therapy to systemic therapy to the presence of a mutation in KRAS.